Halozyme Therapeutics, Inc. (HALO) financial statements (2021 and earlier)

Company profile

Business Address 11388 SORRENTO VALLEY ROAD
SAN DIEGO, CA 92121-1345
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments368120355469205108136
Cash and cash equivalents14812058169674361
Short-term investments220 2973001386574
Receivables9859302216329
Inventory, net of allowances, customer advances and progress billings61292351596
Inventory61292351596
Prepaid expense 30821011
Other undisclosed current assets28304121212209
Total current assets:555543428510257172161
Noncurrent Assets
Property, plant and equipment111174443
Restricted cash and investments1111111
Other undisclosed noncurrent assets141146061
Total noncurrent assets:252212105105
TOTAL ASSETS:580566440520262182166
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities22625448323123
Accounts payable2648443
Accrued liabilities20565040292714
Employee-related liabilities      6
Deferred revenue2 
Debt3972092771722 
Restructuring reserve      1
Deferred revenue and credits47597
Other undisclosed current liabilities 4    (6)
Total current liabilities:42186149131556224
Noncurrent Liabilities
Long-term debt and lease obligation 383    50
Long-term debt, excluding current maturities 383    50
Liabilities, other than long-term debt75755404851
Deferred revenue and credits554404447
Deferred revenue41
Deferred tax liabilities, net    0
Other liabilities3421043
Total noncurrent liabilities:73887554048100
Total liabilities:42947415618695111125
Stockholders' equity
Stockholders' equity attributable to parent15192249208(32)4341
Common stock0000000
Additional paid in capital625695780731553526492
Accumulated other comprehensive income (loss)00(0)(0)(0)(0)(0)
Accumulated deficit(475)(604)(531)(522)(585)(483)(450)
Total stockholders' equity:15192249208(32)4341
Other undisclosed liabilities and equity  3512519928(0)
TOTAL LIABILITIES AND EQUITY:580566440520262182166

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues26819615231714713575
Revenue, net15231714713575
Cost of revenue
(Cost of Goods and Services Sold)
(43)(46)(10)(31)(33)(29)(23)
Gross profit:22415014228511310653
Operating expenses(80)(218)(211)(204)(197)(133)(117)
Other undisclosed operating income      2
Operating income (loss):144(68)(69)81(83)(27)(63)
Nonoperating income5783100
Investment income, nonoperating    100
Other nonoperating income5783   
Interest and debt expense(20)(12)(18)(22)(20)(5)(6)
Income (loss) from continuing operations before equity method investments, income taxes:129(73)(80)62(102)(32)(68)
Other undisclosed income from continuing operations before income taxes 00    
Income (loss) from continuing operations before income taxes:129(72)(80)62(102)(32)(68)
Income tax expense (benefit)(0)0(1)1(1)  
Net income (loss) available to common stockholders, diluted:129(72)(80)63(103)(32)(68)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):129(72)(80)63(103)(32)(68)
Other comprehensive income (loss)(0)0(0)(0)0(0)(0)
Comprehensive income (loss):129(72)(80)63(103)(32)(68)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)10(0)   
Comprehensive income (loss), net of tax, attributable to parent:129(72)(80)63(103)(32)(68)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: